Salivary cortisol sampling compliance: Comparison of patients and healthy volunteers

Psychoneuroendocrinology

Volumn 29, Issue 5, 2004, Pages 636-650

  Broderick, Joan E ^a   Arnold, Daniel ^a   Kudielka, Brigitte M ^b   Kirschbaum, Clemens ^c  

^a STONY BROOK UNIVERSITY   (United States)

^b ETH ZURICH   (Switzerland)

^c HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Adherence; Compliance; Cortisol; Fibromyalgia; FM, fibromyalgia; Salivary cortisol sampling

Indexed keywords

HYDROCORTISONE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE DETERMINATION; HUMAN; INSTRUMENTATION; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; SALIVA; SALIVA ANALYSIS; SELF REPORT; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AWARENESS; FEMALE; FIBROMYALGIA; HUMANS; HYDROCORTISONE; MIDDLE AGED; PATIENT COMPLIANCE; SALIVA; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING;

EID: 1642334789     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(03)00093-3     Document Type: Article

References (22)

1. Boudes P. Drug compliance in therapeutic trials: a review. Controlled Clinical Trials. 19:(3):1998;257-268.
2. Broderick, J., Schwartz, J., Shiffman, S., Hufford, M., Stone, A. Signaling does not adequately improve diary compliance. Annals of Behavioral Medicine, in press.
3. Burney K.D., Krishnan K., Ruffin M.T., Zhang D., Brenner D.E. Adherence to single daily dose of aspirin in a chemoprevention trial. An evaluation of self-report and microelectronic monitoring. Archives of Family Medicine. 5:(5):1996;297-300.
4. Cramer J.A., Scheyer R.D., Mattson R.H. Compliance declines between clinic visits. Archives of Internal Medicine. 150:(7):1990;1509-1510.
5. Dressendorfer R., Kirschbaum C., Rohde W., Stahl F., Strasburger C. Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement. Journal of Steroid Biochem Molecular Biology. 43:1992;683-692.
6. Eissa M.A., Poffenbarger T., Portman R.J. Comparison of the actigraph versus patients' diary information in defining circadian time periods for analyzing ambulatory blood pressure monitoring data. Blood Pressure Monitoring. 6:(1):2001;21-25.
7. Jean-Louis G., Zizi F., von Gizycki H., Hauri P. Actigraphic assessment of sleep in insomnia: application of the Actigraph Data Analysis Software (ADAS). Physiology and Behavior. 65:(4-5):1999;659-663.
8. Kirschbaum C., Read G., Hellhammer D. Assessment of Hormones and Drugs in Saliva in Biobehavioral Research. 1990;Hogrefe & Huber, Seattle.
9. Kudielka B., Broderick J., Kirschbaum C. Compliance with saliva sampling protocols: electronic monitoring reveals invalid cortisol daytime profiles in noncompliant subjects. Psychosomatic Medicine. 65:2003;313-319.
10. Mazze R.S., Shamoon H., Pasmantier R., Lucido D., Murphy J., Hartmann K., Kuykendall V., Lopatin W. Reliability of blood glucose monitoring by patients with diabetes mellitus. American Journal of Medicine. 77:(2):1984;211-217.
11. Nordmann A., Frach B., Walker T., Martina B., Battegay E. Comparison of self-reported home blood pressure measurements with automatically stored values and ambulatory blood pressure. Blood Pressure. 9:(4):2000;200-205.
12. Pruessner J.C., Wolf O.T., Hellhammer D.H., Buske-Kirschbaum A., von Auer K., Jobst S., Kaspers F., Kirschbaum C. Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sciences. 61:(26):1997;2539-2549.
13. Rand C.S., Wise R.A., Nides M., Simmons M.S., Bleecker E.R., Kusek J.W., Li V.C., Tashkin D.P. Metered-dose inhaler adherence in a clinical trial. American Review of Respiratory Disease. 146:(6):1992;1559-1564.
14. Rossy L.A., Buckelew S.P., Dorr N., Hagglund K.J., Thayer J.F., McIntosh M.J., Hewett J.E., Johnson J.C. A meta-analysis of fibromyalgia treatment interventions. Annals of Behavioral Medicine. 21:(2):1999;180-191.
15. Spector S.L., Kinsman R., Mawhinney H., Siegel S.C., Rachelefsky G.S., Katz R.M., Rohr A.S. Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials. Journal of Allergy and Clinical Immunology. 77:(1 Pt 1):1986;65-70.
16. Stone A., Shiffman S., Schwartz J., Broderick J., Hufford M. Patient compliance with paper diaries. British Medical Journal. 324:2002;1193-1194.
17. Urquhart J. Patient non-compliance with drug regimens: measurement, clinical correlates, economic impact. European Heart Journal. 17:(Suppl. A):1996;8-15.
18. Vanhove G.F., Schapiro J.M., Winters M.A., Merigan T.C., Blaschke T.F. Patient compliance and drug failure in protease inhibitor monotherapy. JAMA. 276:(24):1996;1955-1956.
19. Ware J.E. SF-36 Health Survey: Manual and Interpretive Guide. 1993;The Health Institute, New England Medical Center, Boston.
20. Ware J.E., Kosinski M., Dewey J.E. How to Score Version 2 of the SF-36 Health Survey. 2000;QualityMetric Incorporated, Lincoln, RI.
21. Wehr T., Aeschbach D., Duncan W. Evidence for a biological dawn and dusk in the human circadian timing system. Journal of Physiology. 535:(3):2001;937-951.
22. Wolfe, F., Smythe, H.A., Yunus, M.B., Bennett, R.M., Bombardier, C., Goldenberg, D.L., Tugwell, P., Campbell, S.M., Abeles, M., Clark, P., Fam, A.G., Farber, S.J., Fiechtner, J.J., Franklin, C.M., Gatter, R.A., Hamaty, D., Lessard, J., Lichtbroun, A.S., Masi, A.T., et al., 1990. The American College of Rheumatology. Criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis and Rheumatism 33 (2), 160-172.